A Study of TCD601 (Siplizumab) in Newly Diagnosed Adult Amyotrophic Lateral Sclerosis (ALS) Patients

NCT06453668 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
48
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

ITB-Med LLC